Bharat Biotech Unveils Next-Gen Oral Cholera Vaccine To Address Global Health Gaps

HILLCHOL (BBV131), a novel single-strain vaccine is to be administered orally on day 0 and day 14. It is suitable for babies older than one year.

Bharat Biotech Unveils Next-Gen Oral Cholera Vaccine To Address Global Health Gaps
HILLCHOL (BBV131), a novel single-strain vaccine is to be administered orally on day 0 and day 14. It is suitable for babies older than one year.